FS-LASIK
Cross-source consensus on FS-LASIK from 1 sources and 4 claims.
1 sources · 4 claims
Preparation
Risks & contraindications
Comparisons
Highlighted claims
- FS-LASIK is described as the current worldwide gold standard for refractive surgery. — Keratorefractive lenticule extraction (KLEx) versus femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for the treatment of myopia and compound myopic astigmatism: study protocol of a randomised clinical trial in Mexico
- The FS-LASIK procedure in this trial uses an ATOS femtosecond laser for the flap and an Amaris excimer platform for stromal photoablation. — Keratorefractive lenticule extraction (KLEx) versus femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for the treatment of myopia and compound myopic astigmatism: study protocol of a randomised clinical trial in Mexico
- FS-LASIK requires creation of a corneal flap, which introduces flap-related complication risks. — Keratorefractive lenticule extraction (KLEx) versus femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for the treatment of myopia and compound myopic astigmatism: study protocol of a randomised clinical trial in Mexico
- FS-LASIK may induce more spherical aberrations because of flap creation and stromal ablation. — Keratorefractive lenticule extraction (KLEx) versus femtosecond laser-assisted in situ keratomileusis (FS-LASIK) for the treatment of myopia and compound myopic astigmatism: study protocol of a randomised clinical trial in Mexico